Motus GI Holdings Inc (MOTS) USD0.0001
Motus GI Holdings, Inc. is a medical technology company. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. It has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. Its wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.